6 Compounded Semaglutide Providers (2026)
Compounded semaglutide became one of the most prescribed weight-loss medications in the US. The regulatory landscape shifted significantly in 2025–2026. Here is what is still available, what it costs, and what you actually need to know before starting.
Compounded semaglutide from 503A pharmacies is still legally available in 2026 under individual-patient prescriptions — but broader 503B outsourcing facility compounding has faced restriction, and the FDA has been actively tightening enforcement. The cheapest all-in compounded semaglutide we can verify is Henry Meds at $249/mo oral or $297/mo injection; Fridays runs ~$150/mo on an annual plan. These products are not FDA-approved as finished drugs, but they use the same active ingredient as Wegovy and Ozempic. Prices and availability may shift with further regulatory action — re-verify before enrolling.
What you'll actually pay
| Provider | Price / mo | Notes | |
| Henry Medsbest all-in value* | $249–$297/mo* | Compounded 503A semaglutide, all-in (medication, visits, supplies, shipping). Oral from $249/mo; injection from $297/mo. No membership fee. Price does not change with dose escalation. | See |
| Fridays | $150–$249/mo* | Compounded 503A semaglutide, bundled with coaching and dietitian. Month-to-month ~$249/mo; annual commitment ~$150/mo. Tirzepatide also available at similar pricing structure. | See |
| Mochi Health | ~$278/mo* | Compounded 503A semaglutide injection, $199/mo medication + ~$79/mo membership = ~$278 all-in. Flat price across doses. | See |
| Eden | ~$249 → $329/mo* | Compounded 503A semaglutide, first month ~$249; ongoing ~$329. No membership fee; all doses same price. | See |
| Peak Wellness | ~$229 → $349/mo* | Compounded 503A semaglutide, annual-plan rate ~$229/mo; monthly ongoing ~$349. Flat rate across dose levels. | See |
| Ro (limited availability) | $149 + ~$145/mo membership* | Ro pivoted toward brand-name Wegovy post-2025 but may offer compounded semaglutide in limited markets. Verify current availability before starting. Brand-name Wegovy oral available at ~$149/mo NovoCare intro + $145/mo Ro membership. | See |
What compounded semaglutide actually is
Compounded semaglutide is semaglutide prepared by a licensed compounding pharmacy rather than manufactured as a commercial finished product. The active molecule is the same as Wegovy and Ozempic. The difference is the approval status: commercial semaglutide is FDA-approved as a finished drug (specific dose, formulation, manufacturer, tested for safety and efficacy). Compounded semaglutide is not FDA-approved as a finished product — it is prepared under a clinician's prescription for a specific patient.
This distinction matters. The FDA does not review compounded formulations for safety, efficacy, or quality the way it does commercial drugs. However, compounding pharmacies are regulated — 503A pharmacies must comply with state pharmacy laws and the federal DQSA; 503B outsourcing facilities have additional FDA oversight requirements.
Legal status in 2026: still available, but through a narrower pathway
Compounded semaglutide was made widely available by a 2022–2023 FDA drug shortage designation for the brand-name products. Pharmacies could compound semaglutide broadly during that shortage. When the FDA removed semaglutide from the shortage list in early 2024, most broad-scale compounding under the shortage provision ended.
What remains: 503A compounding pharmacies can still legally prepare compounded semaglutide for an individual patient when a prescriber determines there is a clinical need that the commercial drug cannot meet — for example, specific dosing requirements, documented allergies to excipients, or access and cost barriers. The FDA issued warning letters to non-compliant sellers in September 2025 and announced further enforcement steps in February 2026.
The practical implication: compounded semaglutide from a reputable 503A pharmacy, prescribed by a licensed telehealth provider for an individual patient, is still available and still legal. What has changed is that fly-by-night operations and non-compliant compounders have mostly exited or been warned. The providers listed here operate through 503A partnerships.
Henry Meds — best consistent all-in price
Henry Meds stands out because its pricing includes everything — the medication, clinician visits, supplies, and shipping — at a single monthly rate that does not increase with dose escalation. That last point matters: many programs charge more as the dose increases, which means the $199 starting price is not what you pay at month six. Henry Meds' flat-rate structure eliminates that surprise.
- Oral semaglutide: from $249/mo all-in
- Injectable semaglutide: from $297/mo all-in
- No membership, no titration surcharge
- 503A pharmacy, individual-patient prescription
Fridays — cheapest on annual commitment
Fridays' annual plan at ~$150/mo is among the lowest prices for compounded semaglutide with clinical support included. At this price, the program bundles dietitian access, group coaching, and app features. The trade-off is the commitment: at the month-to-month rate ($249/mo), it is comparable to Henry Meds.
One note on Fridays' reviews: its Trustpilot rating is strong (4.4/5 on 4,000+ reviews) but the BBB profile shows a pattern of complaints about refund delays and shipping issues. Factor that in when deciding whether an annual prepayment makes sense for you.
What compounded semaglutide does not include
Compounded semaglutide programs are cash-pay only — they cannot be billed to insurance. There is no manufacturer savings card (those programs apply only to brand-name Wegovy and Ozempic). No patient assistance programs exist for compounded versions. And because it is not FDA-approved, if something goes wrong with the formulation, there is no regulatory recourse available to the patient in the way there is for a commercial drug.
Who compounded semaglutide is and is not for
- Good fit: women who are not covered by insurance for weight-loss medications, have verified eligibility with their provider, and want supervised semaglutide at the lowest available cost
- Not ideal: women who want an FDA-approved product; women with insurance that covers brand-name Wegovy; women who would need ongoing prescription support if the provider exits the market
- Always ask: which 503A pharmacy compounds your medication, and what their quality control and testing protocols are
Frequently asked questions
Is compounded semaglutide the same as Wegovy or Ozempic?+–
It contains the same active molecule — semaglutide — but is a different product. Wegovy and Ozempic are FDA-approved commercial drugs manufactured under strict quality standards. Compounded semaglutide is prepared by a pharmacy for an individual patient and is not FDA-approved as a finished product. The FDA does not review its potency, purity, or sterility the way it does commercial drugs.
Is compounded semaglutide still legal in 2026?+–
Yes, for now — but the regulatory ground has narrowed. 503A pharmacies can still compound semaglutide for individual patients under specific conditions. Broad 503B outsourcing facility compounding without an active shortage designation is no longer permitted. Ongoing FDA enforcement means the landscape could shift further. Verify with your provider before starting.
What is the difference between 503A and 503B compounding?+–
503A pharmacies are traditional compounding pharmacies that prepare medications for individual patient prescriptions. They are regulated by state pharmacy boards and must comply with the federal Drug Quality and Security Act. 503B outsourcing facilities operate at larger scale and have additional FDA oversight — they can supply hospitals and clinics without a patient-specific prescription. Most telehealth GLP-1 programs use 503A pharmacies.
What happens if my provider stops offering compounded semaglutide?+–
Your prescription can typically be transferred to another provider. Your medical records, dosing history, and clinical notes belong to you. If a provider exits the market, they are required to give patients adequate notice and clinical handoff documentation. This is a real scenario worth having a contingency plan for before starting a program.
Can I use compounded semaglutide if I have heart disease or another condition?+–
Some conditions make semaglutide — brand-name or compounded — inappropriate or require careful monitoring (personal/family history of medullary thyroid carcinoma or MEN2, pancreatitis history, and others). The prescribing clinician in any legitimate program will screen for these. Do not start from an online pharmacy that does not require a clinical consultation.